The Association Between Malignancy, Immunodeficiency, and Atopy in IgE-Deficient Patients

Area of Science:

• Immunology
• Oncology
• Clinical Medicine

Background:

• Selective IgE deficiency is linked to increased malignancy prevalence.
• Clinical and laboratory factors contributing to this susceptibility are not well-defined.

Purpose of the Study:

• To investigate the association between malignancy and immunological parameters in IgE-deficient patients.
• To identify specific immune abnormalities that may increase cancer risk in this population.

Main Methods:

• Retrospective analysis of medical records from 408 IgE-deficient adults (2005-2020).
• Evaluation of malignancy diagnosis in relation to atopy status and other humoral immune abnormalities.
• Assessment of specific deficiencies (IgM, IgG2) and CD4 lymphopenia.

Main Results:

• Malignancy was diagnosed in 23.5% of IgE-deficient patients.
• Non-atopic IgE-deficient patients showed higher malignancy odds (OR=4.36).
• IgE-deficient patients with non-common variable immunodeficiency (non-CVID) humoral abnormalities had increased malignancy risk (OR=2.79).
• IgM deficiency (OR=2.46), IgG2 deficiency (OR=10.14), and CD4 lymphopenia (OR=7.81) were associated with higher malignancy odds.

Conclusions:

• Malignancy risk is not uniform among all IgE-deficient patients.
• Further prospective studies are needed to assess the utility of immunological testing for long-term cancer risk stratification.